ISOPROTERENOL HYDROCHLORIDE

N/A

Manufactured by Cipla USA Inc.

894 FDA adverse event reports analyzed

Last updated: 2026-04-15

About ISOPROTERENOL HYDROCHLORIDE

ISOPROTERENOL HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Cipla USA Inc.. The most commonly reported adverse reactions for ISOPROTERENOL HYDROCHLORIDE include DRUG INEFFECTIVE, TORSADE DE POINTES, OFF LABEL USE, VENTRICULAR TACHYCARDIA, ELECTROCARDIOGRAM QT PROLONGED. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ISOPROTERENOL HYDROCHLORIDE.

Top Adverse Reactions

DRUG INEFFECTIVE113 reports
TORSADE DE POINTES39 reports
OFF LABEL USE38 reports
VENTRICULAR TACHYCARDIA27 reports
ELECTROCARDIOGRAM QT PROLONGED23 reports
CARDIOGENIC SHOCK21 reports
TOXIC EPIDERMAL NECROLYSIS20 reports
VENTRICULAR FIBRILLATION20 reports
CARDIAC ARREST19 reports
DRUG INTERACTION19 reports
CONDITION AGGRAVATED18 reports
TOXICITY TO VARIOUS AGENTS18 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION17 reports
BRADYCARDIA16 reports
HYPOTENSION16 reports
OVERDOSE16 reports
PRODUCT USE IN UNAPPROVED INDICATION15 reports
ATRIAL FIBRILLATION14 reports
ACUTE KIDNEY INJURY12 reports
STRESS CARDIOMYOPATHY12 reports
ARRHYTHMIA11 reports
ARRHYTHMIC STORM11 reports
DYSPNOEA11 reports
ATRIOVENTRICULAR BLOCK COMPLETE10 reports
EXPOSURE DURING PREGNANCY10 reports
TREATMENT FAILURE9 reports
VENTRICULAR EXTRASYSTOLES9 reports
ATRIOVENTRICULAR BLOCK8 reports
LONG QT SYNDROME8 reports
SINUS BRADYCARDIA8 reports
ARTERIOSPASM CORONARY7 reports
LOCAL ANAESTHETIC SYSTEMIC TOXICITY7 reports
NODAL ARRHYTHMIA7 reports
RENAL FAILURE7 reports
RESPIRATORY FAILURE7 reports
SEIZURE7 reports
ATRIAL TACHYCARDIA6 reports
CLONUS6 reports
COMA6 reports
MATERNAL EXPOSURE DURING PREGNANCY6 reports
OEDEMA PERIPHERAL6 reports
PREMATURE DELIVERY6 reports
SINUS TACHYCARDIA6 reports
SYNCOPE6 reports
WEIGHT DECREASED6 reports
ABDOMINAL DISCOMFORT5 reports
DRUG LEVEL ABOVE THERAPEUTIC5 reports
FOETAL EXPOSURE DURING PREGNANCY5 reports
INTENTIONAL OVERDOSE5 reports
JOINT SWELLING5 reports
MITOCHONDRIAL TOXICITY5 reports
ORAL HERPES5 reports
PREMATURE BABY5 reports
PYREXIA5 reports
ATRIOVENTRICULAR BLOCK SECOND DEGREE4 reports
BLOOD PRESSURE INCREASED4 reports
CARDIOTOXICITY4 reports
COAGULOPATHY4 reports
COVID 19 PNEUMONIA4 reports
DIABETIC KETOACIDOSIS4 reports
DIZZINESS4 reports
DRUG ABUSE4 reports
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS4 reports
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED4 reports
GALLBLADDER RUPTURE4 reports
HAEMOPERITONEUM4 reports
HEART RATE DECREASED4 reports
INTENTIONAL PRODUCT MISUSE4 reports
INTERVERTEBRAL DISC PROTRUSION4 reports
METABOLIC ACIDOSIS4 reports
MYOCARDIAL INFARCTION4 reports
MYOCARDITIS4 reports
NAUSEA4 reports
NECROTISING OESOPHAGITIS4 reports
PLATELET COUNT DECREASED4 reports
PULSELESS ELECTRICAL ACTIVITY4 reports
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME4 reports
SUPRAVENTRICULAR EXTRASYSTOLES4 reports
THERAPY NON RESPONDER4 reports
WEIGHT INCREASED4 reports
WEIGHT LOSS POOR4 reports
AGITATION3 reports
BONE MARROW FAILURE3 reports
BUNDLE BRANCH BLOCK LEFT3 reports
CAESAREAN SECTION3 reports
CHRONIC KIDNEY DISEASE3 reports
DEVICE MALFUNCTION3 reports
DRUG LEVEL INCREASED3 reports
DRUG WITHDRAWAL SYNDROME3 reports
ELECTROCARDIOGRAM ST SEGMENT ELEVATION3 reports
GINGIVAL HYPERTROPHY3 reports
HAEMODYNAMIC INSTABILITY3 reports
HEADACHE3 reports
HEART RATE INCREASED3 reports
HEART TRANSPLANT REJECTION3 reports
HYPERTENSION3 reports
HYPOPERFUSION3 reports
INTERNATIONAL NORMALISED RATIO INCREASED3 reports
LABELLED DRUG DRUG INTERACTION ISSUE3 reports
MYASTHENIA GRAVIS3 reports

Report Outcomes

Out of 409 classified reports for ISOPROTERENOL HYDROCHLORIDE:

Serious 94.9%Non-Serious 5.1%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male179 (50.4%)
Female176 (49.6%)

Reports by Age

Age 7419 reports
Age 3313 reports
Age 3911 reports
Age 4011 reports
Age 7311 reports
Age 5310 reports
Age 519 reports
Age 699 reports
Age 28 reports
Age 488 reports
Age 638 reports
Age 688 reports
Age 457 reports
Age 547 reports
Age 627 reports
Age 677 reports
Age 716 reports
Age 726 reports
Age 125 reports
Age 185 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with ISOPROTERENOL HYDROCHLORIDE?

This profile reflects 894 FDA FAERS reports that mention ISOPROTERENOL HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for ISOPROTERENOL HYDROCHLORIDE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, TORSADE DE POINTES, OFF LABEL USE, VENTRICULAR TACHYCARDIA, ELECTROCARDIOGRAM QT PROLONGED, CARDIOGENIC SHOCK. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures ISOPROTERENOL HYDROCHLORIDE?

Labeling and FAERS entries often list Cipla USA Inc. in connection with ISOPROTERENOL HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.